Pee test could end painful scope for bladder cancer checks
NCT ID NCT06310759
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a simple urine test that looks for tumor DNA can replace the standard invasive cystoscopy (a camera inserted into the bladder) for diagnosing bladder cancer. Researchers will enroll 3,000 people who have blood in their urine and are scheduled for a cystoscopy. If the urine test proves accurate enough, it could spare many patients from an uncomfortable procedure and reduce healthcare costs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- urine tumor DNA (utDNA) test
- What this could lead to
- If successful, this could replace many invasive cystoscopies with a simple urine test, making diagnosis easier and cheaper for patients with blood in urine.
- What could go wrong
- This is an observational study, not a treatment trial. The urine test may not be accurate enough to replace cystoscopy, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Helsinki University Hospital
RECRUITINGHelsinki, Finland
-
Jesse Brown Department Of Veterans Affairs Medical Center
NOT_YET_RECRUITINGChicago, Illinois, 60612, United States
-
Kindai University Hospital
RECRUITINGOsaka, Japan
-
Satasairaala Hospital
RECRUITINGPori, Finland
-
Seinäjoki Central Hospital
RECRUITINGSeinäjoki, Finland
-
Tampere University Hospital and Tampere University
RECRUITINGTampere, Finland
-
Turku University Hospital
RECRUITINGTurku, Finland
-
Vancouver Prostate Centre
RECRUITINGVancouver, British Columbia, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new nucleotide analogue boost cancer treatment?
- Can a Two-Pronged attack shrink Hard-to-Treat cancers?
- Can a Two-Drug attack shrink Hard-to-Treat bladder tumors?
- Could a lighter immunotherapy schedule keep advanced cancers in check?
- New biologic drug DBC-664 takes aim at Hard-to-Treat cancers
- New antibody aims to unlock immune attack on Hard-to-Treat cancers